Diaceutics PLC (AIM: DXRX), a provider of data analytics and implementation services to the global pharmaceutical industry, announces a trading update for the six months ended 30 June 2019. Trading has continued in line with market expectations and the Company remains well positioned in key markets, underpinned by a strong sales performance.
An increased international footprint has enhanced Diaceutics’ global offering and allowed the Company to acquire new international clients. The Nexus project is progressing as planned.
All outstanding debt has now been retired from the balance sheet resulting in net cash of £14.0m.
The Group’s interim results are expected to be announced in early September.
